Cambridge Investment Research Advisors, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 07, 2021	SELL	$38.75 - $86.92 $246,566 - $553,071	-6,363 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$34.61 - $123.66 $220,223 - $786,848	6,363 New	6,363 $276,000

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

Federated Hermes, Inc. Pittsburgh, PA

4.69M
Shares

$77.6 Million
0.25% of portfolio
Black Rock Inc. New York, NY

2.65M
Shares

$43.8 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

2.32M
Shares

$38.3 Million
0.62% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.28M
Shares

$37.6 Million
0.04% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.1M
Shares

$34.7 Million
0.46% of portfolio

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account